Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives
Abstract Medullary thyroid carcinoma (MTC) is a rare type of thyroid malignancy that accounts for approximately 1–2% of all thyroid cancers (TCs). MTC include hereditary and sporadic cases, the former derived from a germline mutation of rearrangement during transfection (RET) proto-oncogene, whereas...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2024-09-01
|
| Серии: | Cell Communication and Signaling |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12964-024-01837-x |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|